Profund Advisors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Profund Advisors’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,772	Closed	-$326K	–	1201
2024 Q3	$326K	Buy	+9,772	New	+$336K	0.01%	751

Profund Advisors's LBPH Position: Q4 2024 in Review

Profund Advisors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 9,772 shares — an estimated $326K sold.

Profund Advisors first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $326K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Profund Advisors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Profund Advisors sold 9,772 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $326K.
Profund Advisors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Profund Advisors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $326K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Profund Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.